Core Insights - Zhenghai Biological reported an increase in sales expenses primarily due to market promotion of active biological bones and targeted marketing in the oral sector [2] - The decline in revenue was mainly attributed to a decrease in income from the oral segment [2] - The company plans to continue focusing on its advantageous areas and consistently incubate new products to achieve stable revenue growth in the future [2]